FDG PET/CT in the management of nasopharyngeal carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25055290.
- Also identified by DOI 10.2214/AJR.13.12420.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
FDG PET/CT has a growing role in the diagnosis and management of nasopharyngeal carcinoma (NPC). FDG PET has greater efficacy for N and M staging than other modalities, which enables the treating oncologists to select the appropriate mode of treatment. FDG PET/CT helps in radiation therapy planning, provides valuable prognostic information, and is useful in the assessment of therapy response and in follow-up to detect recurrences. FDG PET/CT is a valuable imaging test in the management of NPC.
Medical subject headings
- Fluorodeoxyglucose F18
- Multimodal Imaging
- Nasopharyngeal Neoplasms
- Positron-Emission Tomography
- Radiopharmaceuticals
- Tomography, X-Ray Computed